Literature DB >> 2215087

The association of lysophosphatidylcholine with isolated cardiac myocytes.

R Y Man1, A A Kinnaird, I Bihler, P C Choy.   

Abstract

The ability of exogenous lysophosphatidylcholine to produce electrophysiological derangements and cardiac arrhythmias in the heart has been documented. The action of lysophosphatidylcholine is thought to be mediated via its association with the membrane. The present study examined the nature of the association of lysophosphatidylcholine with isolated rat myocyte membrane. The association was studied by incubating myocytes in a lysophosphatidylcholine-containing medium. The association of lysophosphatidylcholine with the myocyte sarcolemma was not affected by palmitic acid and glycerophosphocholine but was reduced by platelet-activating factor (PAF). The addition of albumin (5 mg/mL) at the end of the incubation period effectively removed the lysophosphatidylcholine from the myocytes. Our results suggest that most of the lysophosphatidylcholine in isolated myocytes was associated preferentially with the outer leaflet of the myocyte sarcolemma. This type of association might be responsible for the lysophosphatidylcholine-induced electrophysiological alterations in the heart.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2215087     DOI: 10.1007/bf02538087

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  20 in total

1.  Lysophosphatidylcholine-induced arrhythmias and its accumulation in the rat perfused heart.

Authors:  R Y Man
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

2.  Lysophosphatidylcholine causes cardiac arrhythmia.

Authors:  R Y Man; P C Choy
Journal:  J Mol Cell Cardiol       Date:  1982-03       Impact factor: 5.000

3.  Isolation of Ca2+-tolerant myocytes from adult rat heart.

Authors:  I Bihler; T K Ho; P C Sawh
Journal:  Can J Physiol Pharmacol       Date:  1984-05       Impact factor: 2.273

Review 4.  Lysophospholipids, long chain acylcarnitines and membrane dysfunction in the ischaemic heart.

Authors:  P B Corr; J E Saffitz; B E Sobel
Journal:  Basic Res Cardiol       Date:  1987       Impact factor: 17.165

5.  Lysophosphatidylcholine accumulation in the ischemic canine heart.

Authors:  A A Kinnaird; P C Choy; R Y Man
Journal:  Lipids       Date:  1988-01       Impact factor: 1.880

6.  Electrophysiologic effects of intracellular lysophosphoglycerides and their accumulation in cardiac lymph with myocardial ischemia in dogs.

Authors:  H Akita; M H Creer; K A Yamada; B E Sobel; P B Corr
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

7.  The effect of lidocaine on lysophosphatidylcholine-induced cardiac arrhythmias and cellular disturbances.

Authors:  K J Neufeld; C L Lederman; P C Choy; R Y Man
Journal:  Can J Physiol Pharmacol       Date:  1985-07       Impact factor: 2.273

8.  On the mechanism of lysophosphatidylcholine-induced depolarization of cat ventricular myocardium.

Authors:  C W Clarkson; R E Ten Eick
Journal:  Circ Res       Date:  1983-05       Impact factor: 17.367

9.  Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium.

Authors:  B E Sobel; P B Corr; A K Robison; R A Goldstein; F X Witkowski; M S Klein
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

10.  Alterations of phospholipids in ischemic canine myocardium during acute arrhythmia.

Authors:  R Y Man; T L Slater; M P Pelletier; P C Choy
Journal:  Lipids       Date:  1983-10       Impact factor: 1.880

View more
  1 in total

1.  Effects of beta-adrenoceptor antagonists on Ca(2+)-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes.

Authors:  M Chen; H Hashizume; Y Abiko
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.